- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 333/68 - Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Patent holdings for IPC class C07D 333/68
Total number of patents in this class: 95
10-year publication summary
|
3
|
6
|
3
|
11
|
9
|
5
|
8
|
6
|
7
|
1
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Astellas Pharma Inc. | 1118 |
7 |
| Enyo Pharma | 58 |
5 |
| Takeda Pharmaceutical Company Limited | 2944 |
3 |
| King Faisal University | 856 |
3 |
| Nflection Therapeutics, Inc. | 33 |
3 |
| Bristol-myers Squibb Company | 4877 |
2 |
| The Regents of the University of California | 19608 |
2 |
| Bayer Pharma AG | 1086 |
2 |
| Activesite Pharmaceuticals, Inc. | 18 |
2 |
| Institut Pasteur Korea | 48 |
2 |
| Kyowa Hakko Kirin Co., Ltd. | 284 |
2 |
| National University Corporation Tokyo Medical and Dental University | 516 |
2 |
| Promega Corporation | 560 |
2 |
| H. Lundbeck A/S | 1241 |
2 |
| Sanofi | 3975 |
2 |
| Janssen Biopharma, Inc. | 49 |
2 |
| The Royal Institution for The Advancement of Learning / McGill University | 669 |
2 |
| Shanghai Yuyao Biotech Ltd. | 10 |
2 |
| Axial Therapeutics, Inc. | 31 |
2 |
| Otcpharm JSC | 3 |
2 |
| Other owners | 44 |